Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Additional Information on Dadra facility receives Warning Letter from USFDA.